Wen-Ting Xie Selected Research

human MIRN124 microRNA

12/2018	Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.
1/2018	Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Ting Xie Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 01/2018
2	Neoplasms (Cancer) 12/2018 - 01/2018
1	Tics (Tic) 12/2018
1	Neoplasm Metastasis (Metastasis) 12/2018
1	follicular Thyroid cancer 12/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Lung Neoplasms (Lung Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2018
2	human MIRN124 microRNAIBA 12/2018 - 01/2018
1	Ubiquitin-Specific ProteasesIBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2018
1	Thyroidectomy 12/2018
1	Therapeutics 01/2018